Anthony J. Polverino - Feb 1, 2022 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role: Director
Signature: /s/ Anthony J. Polverino
Stock symbol: BCLI
Transactions as of: Feb 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/3/2022, 03:33 PM
Previous filing: Jan 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCLI	Common Stock	Award	$0	+3.88K	+17.58%	$0.00	26K	Feb 1, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on March 1, 2022 until fully vested on the first anniversary of February 1, 2022, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.

Content

Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on March 1, 2022 until fully vested on the first anniversary of February 1, 2022, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.